Abstract
BackgroundHypertension and diabetes prevalence is high in Africans. Data from HIV infected populations are limited, especially from Malawi. Integrating care for chronic non-communicable co-morbidities in well-established HIV services may provide benefit for patients by preventing multiple hospital visits but will increase the burden of care for busy HIV clinics.MethodsCross-sectional study of adults (≥18 years) at an urban and a rural HIV clinic in Zomba district, Malawi, during 2014. Hypertension and diabetes were diagnosed according to stringent criteria. Proteinuria, non-fasting lipids and cardio/cerebro-vascular disease (CVD) risk scores (Framingham and World Health Organization/International Society for Hypertension) were determined. The association of patient characteristics with diagnoses of hypertension and diabetes was studied using multivariable analyses. We explored the additional burden of care for integrated drug treatment of hypertension and diabetes in HIV clinics. We defined that burden as patients with diabetes and/or stage II and III hypertension, but not with stage I hypertension unless they had proteinuria, previous stroke or high Framingham CVD risk.ResultsNine hundred fifty-two patients were enrolled, 71.7% female, median age 43.0 years, 95.9% on antiretroviral therapy (ART), median duration 47.7 months. Rural and urban patients’ characteristics differed substantially. Hypertension prevalence was 23.7% (95%-confidence interval 21.1–26.6; rural 21.0% vs. urban 26.5%; p = 0.047), of whom 59.9% had stage I (mild) hypertension. Diabetes prevalence was 4.1% (95%-confidence interval 3.0–5.6) without significant difference between rural and urban settings. Prevalence of proteinuria, elevated total/high-density lipoprotein-cholesterol ratio and high CVD risk score was low. Hypertension diagnosis was associated with increasing age, higher body mass index, presence of proteinuria, being on regimen zidovudine/lamivudine/nevirapine and inversely with World Health Organization clinical stage at ART initiation. Diabetes diagnosis was associated with higher age and being on non-standard first-line or second-line ART regimens.ConclusionAmong patients in HIV care 26.6% had hypertension and/or diabetes. Close to two-thirds of hypertension diagnoses was stage I and of those few had an indication for antihypertensive pharmacotherapy. According to our criteria, 13.0% of HIV patients in care required drug treatment for hypertension and/or diabetes.
Highlights
Hypertension and diabetes prevalence is high in Africans
When comparing the study populations with the overall adult patient populations at each clinic, we found that the study populations were significantly older, longer on anti-retroviral therapy (ART), and less often on the standardized first-line regimen, while only in the urban clinic the percentage of females was higher than in the overall patient population
Hypertension and diabetes prevalence and risk factors Hypertension was diagnosed in 226 patients, resulting in an overall prevalence of 23.7% (95%-CI 21.1–26.6), which included 29 patients (12.8%) already on pharmacotherapy and 166 (73.5%) newly diagnosed cases
Summary
Hypertension and diabetes prevalence is high in Africans. Data from HIV infected populations are limited, especially from Malawi. In a national survey from 2009, high prevalence of hypertension (33%) and diabetes mellitus (6%) was observed in the Malawi general population [1]. Both conditions are likely to become even more common due to population transition effects related to urbanization, life style changes associated with increasing wealth, as well as increasing age of the population [2]. It has been widely argued that hypertension and diabetes mellitus need to get more public health priority [5]. Both conditions are common among HIV infected patients. The adult Malawian population on ART is very large (>550,000 persons) and will continue to grow as eligibility for ART extends
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have